U.S. federal trademark · Serial No. 97436707 · Reg. No. 7134753
Biotechnological platform technology, namely, cell lines for preparation of biological vectors, and recombinant viruses for gene delivery, that includes recombinant adeno-associated viral (rAAV) vectors to provide a platform for specific production of biologics with therapeutic effect in gene therapy, including gene therapy delivery of antibody biologics, enzymes and RNA interference (RNAi)
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.